$7.95
-0.55-6.47%
Last update: Nov 13, 1:43 PM
ORIC Pharmaceuticals Inc
ORICNASDAQ
ORIC Pharmaceuticals fell 30.3% from $12.19 to $8.50, behind the S&P 500's +12.7%. Its worst day was Apr 1 (−41.0%), and its low came Apr 1 at $7.48.
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.33 beat the $-0.40 estimate on $0.00 revenue.
+0.5% · S&P 500 0.0%
EPS of $-0.30 beat the $-0.36 estimate on $0.00 revenue.
Story events cover the past 12 months · Times ET
+14.6% · S&P 500 +0.7%
ORIC Pharmaceuticals shares fell 15.0%, while the S&P 500 rose 0.9%.
−15.0% · S&P 500 +0.9%
ORIC Pharmaceuticals closed at its lowest level of the year, 38.7% below where the year started.
−41.0%, the year's worst day, on 16M shares, the year's heaviest volume · S&P 500 +0.8%
ORIC Pharmaceuticals shares rose 14.7%, while the S&P 500 rose 0.6%.
+14.7% · S&P 500 +0.6%
EPS of $-0.34 missed the $-0.32 estimate on $0.00 revenue.
−0.6% · S&P 500 +0.8%
ORIC Pharmaceuticals shares fell 15.1%, while the S&P 500 rose 0.1%.
−15.1% · S&P 500 +0.1%
EPS of $-0.38 missed the $-0.36 estimate on $0.00 revenue.
+27.1%, the year's best day · S&P 500 +1.8%
ORIC Pharmaceuticals closed at its highest level of the year, 20.2% above where the year started.
+5.2% · S&P 500 +0.2%
ORIC Pharmaceuticals shares fell 32.0%, while the S&P 500 rose 0.7%.
−32.0% · S&P 500 +0.7%
Where it ended: a close of $8.50 on Nov 12, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-0.39).
Nothing in the past 12 months.
All ORIC dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ORIC and SPY from Benzinga historical bars. Not investment advice.
